Atlas Trials

Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC

Clinical trial NCT01742767 · UNKNOWN

Trial details

NCT number
NCT01742767
Sponsor
Universität Duisburg-Essen
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
NSCLC
Start date
2012-11-01
Primary completion
2014-05-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.